메뉴 건너뛰기




Volumn 31, Issue 4, 2012, Pages 585-594

Managing cardiovascular risk in patients with chronic inflammatory diseases

Author keywords

Cardiovascular disease; Inflammatory diseases; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; ETANERCEPT; GLUCOCORTICOID; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MINOCYCLINE; PENICILLAMINE; PREDNISONE; ROFECOXIB; SALAZOSULFAPYRIDINE;

EID: 84859741441     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1921-0     Document Type: Review
Times cited : (23)

References (50)
  • 1
    • 70349389455 scopus 로고    scopus 로고
    • ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures
    • (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research
    • Redberg RF, Benjamin EJ, Bittner V et al (2009) ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J Am Coll Cardiol 54:1364-1405
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1364-1405
    • Redberg, R.F.1    Benjamin, E.J.2    Bittner, V.3
  • 2
    • 70350360003 scopus 로고    scopus 로고
    • 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations
    • Genest J, McPherson R, Frohlich J et al (2009) 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 25:567-579
    • (2009) Can J Cardiol , vol.25 , pp. 567-579
    • Genest, J.1    McPherson, R.2    Frohlich, J.3
  • 4
    • 67449110958 scopus 로고    scopus 로고
    • Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality
    • Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG (2009) Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 145:700-703
    • (2009) Arch Dermatol , vol.145 , pp. 700-703
    • Prodanovich, S.1    Kirsner, R.S.2    Kravetz, J.D.3    Ma, F.4    Martinez, L.5    Federman, D.G.6
  • 7
    • 0037225374 scopus 로고    scopus 로고
    • Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis
    • Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36-40 (Pubitemid 36077769)
    • (2003) Journal of Rheumatology , vol.30 , Issue.1 , pp. 36-40
    • Wolfe, F.1    Freundlich, B.2    Straus, W.L.3
  • 8
    • 17644412023 scopus 로고    scopus 로고
    • Inflammation, atherosclerosis, and coronary artery disease
    • Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
    • (2005) N Engl J Med , vol.352 , pp. 1685-1695
    • Hansson, G.K.1
  • 9
    • 0036790573 scopus 로고    scopus 로고
    • Association of C-reactive protein with carotid atherosclerosis in men and women: The Framingham Heart Study
    • Wang TJ, Nam BH, Wilson PW et al (2002) Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 22:1662-1667
    • (2002) Arterioscler Thromb Vasc Biol , vol.22 , pp. 1662-1667
    • Wang, T.J.1    Nam, B.H.2    Wilson, P.W.3
  • 12
  • 13
    • 77951099590 scopus 로고    scopus 로고
    • Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the General Practice Research Database
    • Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31:1000-1006
    • (2010) Eur Heart J , vol.31 , pp. 1000-1006
    • Mehta, N.N.1    Azfar, R.S.2    Shin, D.B.3    Neimann, A.L.4    Troxel, A.B.5    Gelfand, J.M.6
  • 14
    • 70349960058 scopus 로고    scopus 로고
    • Prevalence of myocardial infarction in patients with psoriasis in Central China
    • Xiao J, Chen LH, Tu YT, Deng XH, Tao J (2009) Prevalence of myocardial infarction in patients with psoriasis in Central China. J Eur Acad Dermatol Venereol 23:1311-1315
    • (2009) J Eur Acad Dermatol Venereol , vol.23 , pp. 1311-1315
    • Xiao, J.1    Chen, L.H.2    Tu, Y.T.3    Deng, X.H.4    Tao, J.5
  • 16
    • 0037643388 scopus 로고    scopus 로고
    • All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database
    • Watson DJ, Rhodes T, Guess HA (2003) All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 30:1196-1202 (Pubitemid 36666340)
    • (2003) Journal of Rheumatology , vol.30 , Issue.6 , pp. 1196-1202
    • Watson, D.J.1    Rhodes, T.2    Guess, H.A.3
  • 18
    • 77956503955 scopus 로고    scopus 로고
    • Explaining the cardiovascular risk associated with rheumatoid arthritis: Traditional risk factors versus markers of rheumatoid arthritis severity
    • Solomon DH, Kremer J, Curtis JR et al (2010) Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 69:1920-1925
    • (2010) Ann Rheum Dis , vol.69 , pp. 1920-1925
    • Solomon, D.H.1    Kremer, J.2    Curtis, J.R.3
  • 19
    • 61649109296 scopus 로고    scopus 로고
    • Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies
    • Driessen RJ, Boezeman JB, van de Kerkhof PC, de Jong EM (2009) Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatolog Treat 20:42-47
    • (2009) J Dermatolog Treat , vol.20 , pp. 42-47
    • Driessen, R.J.1    Boezeman, J.B.2    Van De Kerkhof, P.C.3    De Jong, E.M.4
  • 20
    • 22244443784 scopus 로고    scopus 로고
    • Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
    • Jacobsson LT, Turesson C, Gulfe A et al (2005) Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32:1213-1218 (Pubitemid 40995372)
    • (2005) Journal of Rheumatology , vol.32 , Issue.7 , pp. 1213-1218
    • Jacobsson, L.T.H.1    Turesson, C.2    Gulfe, A.3    Kapetanovic, M.C.4    Petersson, I.F.5    Saxne, T.6    Geborek, P.7
  • 21
    • 75749118959 scopus 로고    scopus 로고
    • EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
    • Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325-331
    • (2010) Ann Rheum Dis , vol.69 , pp. 325-331
    • Peters, M.J.1    Symmons, D.P.2    McCarey, D.3
  • 22
    • 22444441665 scopus 로고    scopus 로고
    • Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis
    • Hippisley-Cox J, Coupland C (2005) Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 330:1366
    • (2005) BMJ , vol.330 , pp. 1366
    • Hippisley-Cox, J.1    Coupland, C.2
  • 23
    • 18344368896 scopus 로고    scopus 로고
    • Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: A population-based case-control study
    • DOI 10.1001/archinte.165.9.978
    • Johnsen SP, Larsson H, Tarone RE et al (2005) Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 165:978-984 (Pubitemid 40638117)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.9 , pp. 978-984
    • Johnsen, S.P.1    Larsson, H.2    Tarone, R.E.3    McLaughlin, J.K.4    Norgard, B.5    Friis, S.6    Sorensen, H.T.7
  • 24
    • 49549121830 scopus 로고    scopus 로고
    • Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case-control study
    • Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F (2008) Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 59:1090-1096
    • (2008) Arthritis Rheum , vol.59 , pp. 1090-1096
    • Nadareishvili, Z.1    Michaud, K.2    Hallenbeck, J.M.3    Wolfe, F.4
  • 25
    • 73249133520 scopus 로고    scopus 로고
    • Pooled analysis of rofecoxib placebo-controlled clinical trial data: Lessons for postmarket pharmaceutical safety surveillance
    • Ross JS, Madigan D, Hill KP, Egilman DS, Wang Y, Krumholz HM (2009) Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance. Arch Intern Med 169:1976-1985
    • (2009) Arch Intern Med , vol.169 , pp. 1976-1985
    • Ross, J.S.1    Madigan, D.2    Hill, K.P.3    Egilman, D.S.4    Wang, Y.5    Krumholz, H.M.6
  • 27
    • 19644401171 scopus 로고    scopus 로고
    • Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
    • Wei L, MacDonald TM, Walker BR (2004) Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764-770
    • (2004) Ann Intern Med , vol.141 , pp. 764-770
    • Wei, L.1    MacDonald, T.M.2    Walker, B.R.3
  • 28
    • 51849097776 scopus 로고    scopus 로고
    • The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis
    • Wolfe F, Michaud K (2008) The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 58:2612-2621
    • (2008) Arthritis Rheum , vol.58 , pp. 2612-2621
    • Wolfe, F.1    Michaud, K.2
  • 29
    • 3442876736 scopus 로고    scopus 로고
    • Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study
    • DOI 10.1136/hrt.2003.020180
    • Souverein PC, Berard A, Van Staa TP et al (2004) Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90:859-865 (Pubitemid 39005927)
    • (2004) Heart , vol.90 , Issue.8 , pp. 859-865
    • Souverein, P.C.1    Berard, A.2    Van Staa, T.P.3    Cooper, C.4    Egberts, A.C.G.5    Leufkens, H.G.M.6    Walker, B.R.7
  • 30
    • 0037029418 scopus 로고    scopus 로고
    • Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study
    • DOI 10.1016/S0140-6736(02)08213-2
    • Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173-1177 (Pubitemid 34304256)
    • (2002) Lancet , vol.359 , Issue.9313 , pp. 1173-1177
    • Choi, H.K.1    Hernan, M.A.2    Seeger, J.D.3    Robins, J.M.4    Wolfe, F.5
  • 31
    • 24644497608 scopus 로고    scopus 로고
    • Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis
    • Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS (2005) Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 52:262-267
    • (2005) J Am Acad Dermatol , vol.52 , pp. 262-267
    • Prodanovich, S.1    Ma, F.2    Taylor, J.R.3    Pezon, C.4    Fasihi, T.5    Kirsner, R.S.6
  • 32
    • 0034611896 scopus 로고    scopus 로고
    • Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
    • Landewe RB, van den Borne BE, Breedveld FC, Dijkmans BA (2000) Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 355:1616-1617 (Pubitemid 30240511)
    • (2000) Lancet , vol.355 , Issue.9215 , pp. 1616-1617
    • Landewe, R.B.M.1    Van Den, B.B.E.E.M.2    Breedveld, F.C.3    Dijkmans, B.A.C.4
  • 34
    • 47849128962 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis
    • Setoguchi S, Schneeweiss S, Avorn J et al (2008) Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J 156:336-341
    • (2008) Am Heart J , vol.156 , pp. 336-341
    • Setoguchi, S.1    Schneeweiss, S.2    Avorn, J.3
  • 35
    • 1242315583 scopus 로고    scopus 로고
    • Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy
    • DOI 10.1016/j.amjmed.2003.09.039
    • Wolfe F, Michaud K (2004) Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 116:305-311 (Pubitemid 38230289)
    • (2004) American Journal of Medicine , vol.116 , Issue.5 , pp. 305-311
    • Wolfe, F.1    Michaud, K.2
  • 37
    • 21244436822 scopus 로고    scopus 로고
    • Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
    • DOI 10.1093/rheumatology/keh610
    • Bernatsky S, Hudson M, Suissa S (2005) Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis. Rheumatology (Oxford) 44:677-680 (Pubitemid 41487243)
    • (2005) Rheumatology , vol.44 , Issue.5 , pp. 677-680
    • Bernatsky, S.1    Hudson, M.2    Suissa, S.3
  • 38
    • 78249272692 scopus 로고    scopus 로고
    • No evidence of association between anti-TNF treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
    • Lunt M, Watson KD, Dixon WG, Symmons DP, Hyrich KL (2010) No evidence of association between anti-TNF treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 62:3145-3153
    • (2010) Arthritis Rheum , vol.62 , pp. 3145-3153
    • Lunt, M.1    Watson, K.D.2    Dixon, W.G.3    Symmons, D.P.4    Hyrich, K.L.5
  • 39
    • 0038755661 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial
    • DOI 10.1161/01.CIR.0000077913.60364.D2
    • Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107:3133-3140 (Pubitemid 36793081)
    • (2003) Circulation , vol.107 , Issue.25 , pp. 3133-3140
    • Chung, E.S.1    Packer, M.2    Lo, K.H.3    Fasanmade, A.A.4    Willerson, J.T.5
  • 40
    • 33845875445 scopus 로고    scopus 로고
    • Cardiovasc. risk reduction in high-risk Pediat. patients: A Sci. statement from the AHA Expert Panel on Pop. and Prev. Sci.; the Councils on Cardiovasc. Dis. in the Young, Epidemiol. and Prev., Nutr., Phys. Activ. and Metab., HBPR, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the AAP
    • Kavey RE, Allada V, Daniels SR et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114:2710-2738
    • (2006) Circulation , vol.114 , pp. 2710-2738
    • Kavey, R.E.1    Allada, V.2    Daniels, S.R.3
  • 41
    • 33745884118 scopus 로고    scopus 로고
    • Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis
    • DOI 10.1002/art.21932
    • Van Doornum S, Brand C, King B, Sundararajan V (2006) Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum 54:2061-2068 (Pubitemid 44051061)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.7 , pp. 2061-2068
    • Van Doornum, S.1    Brand, C.2    King, B.3    Sundararajan, V.4
  • 46
    • 33846996345 scopus 로고    scopus 로고
    • Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score
    • Ridker PM, Buring JE, Rifai N, Cook NR (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA297:611-619
    • (2007) JAMA , vol.297 , pp. 611-619
    • Ridker, P.M.1    Buring, J.E.2    Rifai, N.3    Cook, N.R.4
  • 47
    • 33748528641 scopus 로고    scopus 로고
    • Indications for lowering LDL cholesterol in rheumatoid arthritis: An unrecognized problem
    • Soubrier M, Zerkak D, Dougados M (2006) Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem. J Rheumatol 33:1766-1769 (Pubitemid 44373208)
    • (2006) Journal of Rheumatology , vol.33 , Issue.9 , pp. 1766-1769
    • Soubrier, M.1    Zerkak, D.2    Dougados, M.3
  • 48
    • 33645465405 scopus 로고    scopus 로고
    • Reducing the cardiovascular disease burden in rheumatoid arthritis
    • Van Doornum S, Jennings GL, Wicks IP (2006) Reducing the cardiovascular disease burden in rheumatoid arthritis. Med J Aust 184:287-290
    • (2006) Med J Aust , vol.184 , pp. 287-290
    • Van Doornum, S.1    Jennings, G.L.2    Wicks, I.P.3
  • 49
    • 33744929376 scopus 로고    scopus 로고
    • Therapy insight: Managing cardiovascular risk in patients with rheumatoid arthritis
    • DOI 10.1038/ncprheum0178, PII N0178
    • Giles JT, Post W, Blumenthal RS, Bathon JM (2006) Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2:320-329 (Pubitemid 43842261)
    • (2006) Nature Clinical Practice Rheumatology , vol.2 , Issue.6 , pp. 320-329
    • Giles, J.T.1    Post, W.2    Blumenthal, R.S.3    Bathon, J.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.